This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.

 
Web www.patentalert.com

< INGAP protein involved in pancreatic islet neogenesis

< Modular targeted liposomal delivery system

> Metal-containing compositions, preparations and uses

> Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications and preparations
~ 00270